October 3, 2022 – Florida Atlantic University’s Charles E. Schmidt College of Medicine and the Max Planck Florida Institute for Neuroscience (MPFI) will announce its new M.D./Ph.D. dual-degree program with a memorandum of understanding (MOU) signing on Tuesday, Oct. 4 at 10 a.m., at MPFI, 1 Max Planck Way, second floor atrium, in Jupiter.
The new M.D./Ph.D. dual-degree program will increase educational opportunities for students interested in cutting-edge research while incorporating those developments into innovative treatment plans.
With the addition of this academic program, FAU-Max Planck Joint Programs offers academic and research opportunities from the high school, undergraduate, graduate, Ph.D. – and now – M.D. levels.
FAU President John Kelly; David Fitzpatrick, Ph.D., MPFI scientific director and CEO; Julie Pilitsis, M.D., Ph.D., dean of the Schmidt College of Medicine, and other representatives from collaborating agencies will be available for interviews.
To RSVP for media attendance, contact Bethany Alex at 561-876-7411 or bethanyalex@fau.edu by Monday, Oct. 3 at noon.
About Florida Atlantic University:
Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida. Today, the University serves more than 30,000 undergraduate and graduate students across six campuses located along the southeast Florida coast. In recent years, the University has doubled its research expenditures and outpaced its peers in student achievement rates. Through the coexistence of access and excellence, FAU embodies an innovative model where traditional achievement gaps vanish. FAU is designated a Hispanic-serving institution, ranked as a top public university by U.S. News & World Report and a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching. For more information, visit www.fau.edu.
About the Max Planck Florida Institute for Neuroscience:
The Max Planck Florida Institute for Neuroscience (MPFI), a not-for-profit research organization, is part of the world-renowned Max Planck Society, Germany’s most successful research organization with 86 institutes worldwide. Since its establishment in 1948, 22 Nobel laureates have emerged from the ranks of its scientists. As its first U.S. institution, MPFI provides exceptional neuroscientists from around the world with the resources and technology to answer fundamental questions about brain development and function. MPFI researchers employ a curiosity-driven approach to science to develop new technologies that make groundbreaking scientific discoveries possible. For more information, visit https://www.mpfi.org/.
